Emerald Advisers, LLC

SEC CIK: 0001015083
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overview All 13F holders of KROS Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of KROS by Emerald Advisers, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−244,633−100.0%	Sold out	Holders
Q4 2024	244,633	$3.87M	0.2%	+89,088+57.3%	Added	Holders
Q3 2024	155,545	$9.03M	0.3%	+155,545	New	Holders